India virus covid-19 India

Remdesivir manufacturers to cut price, ramp up production amid Covid-19 spike

Reading now: 661
www.livemint.com

₹3,500 by the end of this week in order to contain the spread of the virus and contribute to the Centre's efforts.They have also been directed to give priority to fulfil hospital/institutional level supplies.Meanwhile, Union health Minster Harsh Vardhan today said, "Shortage of Remdesivir happened because its production was reduced as COVID-19 cases were decreasing.

Our drug controller and ministry held a meeting with stakeholders and asked manufacturers to strengthen the production."As an additional measure, Remdesivir, API and formulation were placed under Export ban on 11.04.2021 by DGFT to increase the supply of Remdesivir in the Domestic Market.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA